Advertisement

Topics

Theradiag and Biogen Sign a Partnership Agreement

12:02 EST 14 Nov 2017 | FinanzNachrichten

Lisa Tracker monitoring kits will be provided with the Flixabi biosimilar Regulatory News: THERADIAG (Paris:ALTER)(ISIN code: FR0004197747, Ticker: ALTER) a company specialized in in vitro diagnos...

Original Article: Theradiag and Biogen Sign a Partnership Agreement

NEXT ARTICLE

More From BioPortfolio on "Theradiag and Biogen Sign a Partnership Agreement"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...